Hadox Research Labs · Science Intelligence
We watch the research landscape, compare papers with fair peers, read the full text and publish the receipts. No journal logo, citation count or model gets the last word alone.
Current truthThe ascendance engine is still building history. This edition is editorially selected, not algorithmically declared “rising.”
Comparison universe1,138 current candidates across 41 age, field and article-type cohorts.
Evidence gateEvery public dossier was read from an authorised full body. Abstract-only records remain ineligible.
As of25 Jul 2026
This public, sanitized index unites the observatory with Hadox's reviewed dossiers. Bibliographic metadata and measured signal states are visible; abstracts and source text are not.
Tracking is not endorsement. A row means Hadox is monitoring the paper or has completed a public dossier. Radar states appear only when measured against age-, field- and article-type peers; no metric is invented for editorial selections.
Read the selection method| Paper | Field | Radar state | Attention | Next review | Hadox |
|---|---|---|---|---|---|
| A comparison of deep multiomics profiles across ethnicity, geography, and age Cell · 2026-05-01 · 10.1016/j.cell.2026.04.032 | Biochemistry, Genetics and Molecular Biology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 31% · 31 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy Cell · 2026-05-01 · 10.1016/j.cell.2026.03.002 | Oncology Research article | Baseline Candidate · 1 signal point | 7 citations Cohort 75% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Advancing tau-PET imaging in Alzheimer's disease The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00809-3 | Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 30% · 65 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Alzheimer's disease neuropathology plasma biomarkers and cognition in midlife: a community-based cohort study The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00515-5 | Medicine Research article | Baseline Candidate · 1 signal point | 3 citations Cohort 85% · 65 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Arbitrium phages can manipulate each other’s lysis/lysogeny decisions Cell · 2026-05-01 · 10.1016/j.cell.2026.02.020 | Environmental Science Research article | Baseline Candidate · 1 signal point | 4 citations Cohort 89% · 9 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Autoantibodies in long COVID: A mechanistic foothold in a heterogeneous disease Cell · 2026-05-01 · 10.1016/j.cell.2026.04.044 | Neurology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 20% · 5 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| B cells just got a workout Cell · 2026-05-01 · 10.1016/j.cell.2026.04.046 | Physiology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 50% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Blood biomarkers for Alzheimer's disease: from detection to decisions The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00909-8 | Physiology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 50% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Broadening metrics in the Lancet Countdown on health and climate change The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00311-9 | Environmental Science Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 17% · 9 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Clinical implications and biomarkers in the PACT-21 CASSANDRA trial The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00642-2 | Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 30% · 65 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Controlled human influenza infection reveals heterogeneous expulsion of infectious virus into air Cell · 2026-05-01 · 10.1016/j.cell.2026.02.025 | Pulmonary and Respiratory Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 30% · 5 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Decoding the spatiotemporal development of human meninges Cell · 2026-05-01 · 10.1016/j.cell.2026.04.040 | Neuroscience Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 33% · 9 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Department of Error The Lancet · 2026-05-01 · 10.1016/s0140-6736(26)00990-6 | Cardiology and Cardiovascular Medicine Research article | Baseline Candidate · 1 signal point | 1 citations Cohort 90% · 5 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Development of non-spatial grid-like neural codes tracks inference and intelligence Cell · 2026-05-01 · 10.1016/j.cell.2026.02.028 | Physical Sciences Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 31% · 36 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Disrupted molecular glue complex drives RAS inhibitor resistance Cell · 2026-05-01 · 10.1016/j.cell.2026.03.031 | Oncology Research article | Baseline Candidate · 1 signal point | 5 citations Cohort 58% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
These are the exact visual editions already shared by Hadox. Each one now has a canonical source, immutable assets and a visible workflow state; publication history never substitutes for scientific review.
01
The source is identified, but no authorised full body is available for Hadox review yet.
02
Published edition linked to a full-text Hadox evidence dossier.
03
This official-source story is awaiting the institutional evidence workflow.
Historical copy retained; correction logged in the workflow.
Today, 0 papers have enough history for a momentum score and 0 public dossiers were selected by an open ascendance gate. That is not a failure to hide; it is the calibration state.
current paper assessments from Crossref + Openalex
cohorts split by paper age, article type and discipline
baseline · 1 watch · 0 rising
01Observe attention against fair peers.
02Wait for enough history to measure velocity.
03Read the authorised full paper and map every claim.
04Make a separate editorial decision and publish the evidence.